K. Lundgren

发表

Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study

Jack Cuzick, Mitch Dowsett, Lila Zabaglo, 2012, Breast Cancer Research.

Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer

B. Nordenskjöld, G. Landberg, K. Lundgren, 2009, British Journal of Cancer.

Hypoxia and breast cancer: prognostic and therapeutic implications.

G. Landberg, C. Holm, K. Lundgren, 2007, Cellular and molecular life sciences : CMLS.

Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.

G. Landberg, N. Tobin, L. Anagnostaki, 2012, Human pathology.

Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer

G. Landberg, C. Holm, K. Lundgren, 2007, Cellular and Molecular Life Sciences.

Differential expression of cytoplasmic and stromal β-arrestin-1 is associated with separate aspects of tumor behavior in breast cancer

K. Jirström, G. Landberg, K. Lundgren, 2009, Breast Cancer Research.

Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.

K. Jirström, L. Rydén, O. Stål, 2011, The Journal of molecular diagnostics : JMD.

Cyclin D1, Id1 and EMT in breast cancer

G. Landberg, N. Tobin, A. Sims, 2011, BMC Cancer.

Prognostic and Treatment Predictive Markers Associated with Cyclin D1 Gene Amplification and Epithelial-Mesenchymal Transition in Breast Cancer

K. Lundgren, Katja L Lundgren, 2010 .

Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer

Å. Borg, K. Holm, B. Nordenskjöld, 2008, Breast Cancer Research.